ConductScience.org, home

Paper29948899

N-terminal domain of the RNA polymerase of very virulent infectious bursal disease virus contributes to viral replication and virulence.

Gao L and 6 others. Sci China Life Sci, 2018. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. N-terminal domain of the RNA polymerase of very virulent infectious bursal disease virus contributes to viral replication and virulence. Papers, record 29948899. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29948899

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
N-terminal domain of the RNA polymerase of very virulent infectious bursal disease virus contributes to viral replication and virulence.
PubMed
Journal
Sci China Life Sci
PubMed
Year
2018
PubMed
Publication types
Letter
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.59
iCite
Revised in PubMed
2018-12-11
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gao LLi
2Li KKai
3Qi XXiaole
4Gao YYulong
5Wang YYongqiang
6Gao HHonglei
7Wang XXiaomei

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DNA-Directed RNA PolymerasesMajor topic
Infectious bursal disease virusMajor topic
Viral Structural ProteinsMajor topic
Virus ReplicationMajor topic
Animals
Binding Sites
Birnaviridae Infections
Chickens
Poultry Diseases
Virulence

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
41472004Advances in Infectious Bursal Disease Virus Vaccines-A Review.Microorganisms2025https://conductscience.org/library/papers/41472004PubMed
39268520
The complete protections induced by the oil emulsion vaccines of the novel variant infectious bursal disease viruses against the homologous challenges indicating the important roles of both VP2 and VP1 in the antigenicity and pathogenicity of the virus.
Front Vet Sci2024https://conductscience.org/library/papers/39268520PubMed
38075867
Genetic and pathogenic characterizations of a naturally occurring reassortant and homologous recombinant strain of the classical infectious bursal disease virus re-emerging in chickens in southern China.
Front Microbiol2023https://conductscience.org/library/papers/38075867PubMed
37175960Genetic Insight into the Interaction of IBDV with Host-A Clue to the Development of Novel IBDV Vaccines.Int J Mol Sci2023https://conductscience.org/library/papers/37175960PubMed
33466596
The Full Region of N-Terminal in Polymerase of IBDV Plays an Important Role in Viral Replication and Pathogenicity: Either Partial Region or Single Amino Acid V4I Substitution Does Not Completely Lead to the Virus Attenuation to Three-Yellow Chickens.
Viruses2021https://conductscience.org/library/papers/33466596PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29948899

GET https://conductscience.org/api/papers/v1/29948899/authors